@article{VILLALBASAORIN:111568,
author = "VILLALBA SAORIN, ANTONIO JESUS and Gómez Vallejo, Jesús",
title = "{Antiagregantes y fractura de cadera}",
year = "2019",
note = "Resumen disponible también en inglés: Background and
objective: The purpose of our study was to check whether
antiplatelet therapy of any kind significantly decreases
the mortality of patients who have suffered a hip fracture,
based on a reduction in inflammation caused by the
fracture. Patients and objectives: An observational,
longitudinal and retrospective study has been carried out,
in which we have included all the patients treated in our
hospital, in the year 2016, a total of 422 patients, who
were divided into two groups, depending on whether they
were antiaggregates. After the fracture, to analyze their
intrahospital mortality, month, at 12 months and at 40
months. Results: Antiplatelet therapy reduced mortality
significantly in the month after fracture (p = 0.047), then
the differences were not significant, with a tendency to
match the mortalities of both groups. Conclusions: We
believe that reducing short-term mortality may have
resulted from the anti-inflammatory effect of
antiplatelets. It is necessary to carry out a more potent
study, to confirm our results, and to let us know if it
would be indicated to treat all patients with hip fractures
with antiplatelets.",
}